| 英文名 | 2-[(1S)-1-[(3aS,4E,7aS)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-1-yl]ethoxy]-N-(2,2,3,3,3-pentafluoropropyl)acetamide | 
|---|---|
| 英文别名 | 2-{[(1S,3R,5Z,7E,9ξ,20S)-1,3-Dihydroxy-9,10-secopregna-5,7,10,16-tetraen-20-yl]oxy}-N-(2,2,3,3,3-pentafluoropropyl)acetamide M5181 Pefcalcitol 2-(((1S,3R,5z,7E,20S)-1,3-dihydroxy-9,10-secopregna-5,7,10(19),16-tetraen-20-yl)oxy)-N-(2,2,3,3,3-pentafluoropropyl)acetamide UNII-KT5224XSHW Acetamide,2-((1S)-1-((3aS,7E,7as)-7-((2Z)-((3S,5R)-3,5-dihydroxy-2-methylenecyclohexylidene)ethylidene)-3a,4,5,6,7,7a-hexahydro-3a-methyl-1H-inden-3-yl)ethoxy)-N-(2,2,3,3,3-pentafluoropropyl) Acetamide, 2-[(1S)-1-[(3aS,7E,7aS)-7-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylenecyclohexylidene]ethylidene]-3a,4,5,6,7,7a-hexahydro-3a-methyl-1H-inden-3-yl]ethoxy]-N-(2,2,3,3,3-pentafluoropropyl)- Pefcalcitol [INN] | 
| 描述 | Pefcalcitol是一种具有16-en-22-oxa-维生素D3结构的新型抗溃疡药物候选药物。 | 
|---|---|
| 相关类别 | |
| 参考文献 | 
| 密度 | 1.3±0.1 g/cm3 | 
|---|---|
| 沸点 | 614.0±55.0 °C at 760 mmHg | 
| 分子式 | C26H34F5NO4 | 
| 分子量 | 519.544 | 
| 闪点 | 325.1±31.5 °C | 
| 精确质量 | 519.240784 | 
| PSA | 82.28000 | 
| LogP | 5.42 | 
| 蒸汽压 | 0.0±4.0 mmHg at 25°C | 
| 折射率 | 1.523 |